Clinical Drug Experience Knowledgebase

Affective Symptoms (Phase 4)

Aggression (Phase 2)

Alcohol Drinking (Phase 2)

Alcoholism (Phase 2)

Alzheimer Disease (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 2)

Anemia, Iron-Deficiency (Phase 4)

Astrocytoma (Phase 3)

Carcinoma, Neuroendocrine (Phase 2)

Communicable Diseases (Phase 4)

Dementia (Phase 3)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Disease (Phase 4)

Embolism (Phase 3)

Glioblastoma (Phase 3)

Glioma (Phase 3)

Heart Failure (Phase 4)

Heart Failure, Systolic (Phase 4)

Hypertrophy (Phase 2)

Hypertrophy, Left Ventricular (Phase 2)

Immunoblastic Lymphadenopathy (Phase 3)

Infarction (Phase 2)

Infections (Phase 4)

Lymphadenopathy (Phase 3)

Lymphoma (Phase 3)

Lymphoma, Extranodal NK-T-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell (Phase 3)

Lymphoma, T-Cell, Peripheral (Phase 3)

Macular Degeneration (Phase 4)

Mental Disorders (Phase 4)

Motor Neuron Disease (Phase 2)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Myocardial Infarction (Phase 2)

Neoplasms, Neuroepithelial (Phase 3)

Nephritis, Hereditary (Phase 3)

Neuritis (Phase 2)

Neuroendocrine Tumors (Phase 2)

Obesity (Phase 2)

Optic Neuritis (Phase 2)

Panic Disorder (Phase 4)

Prostatic Neoplasms (Phase 3)

Psychotic Disorders (Phase 4)

Pulmonary Embolism (Phase 3)

Recurrence (Phase 2)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Schizophrenia (Phase 4)

Shock (Phase 3)

Shock, Cardiogenic (Phase 2)

Shock, Septic (Phase 3)

Sinusitis (Phase 3)

Syndrome (Phase 3)

Urinary Tract Infections (Phase 4)